Chugai Pharmaceutical Co., Ltd.
Phone: 81-(0)3-3281-6611
Fax: 81-(0)3-3281-6607
E-mail: Via Site
Web: https://www.chugai-pharm.co.jp
| Native name | 中外製薬株式会社 |
|---|---|
| Romanized name | Chūgai Seiyaku kabushiki gaisha |
| Type | Public KK |
| Traded as |
|
| Industry | Pharmaceutical Industry, Business import, production and development of drugs for medical sales |
| Founded | March 8, 1943 |
| Headquarters | Nihonbashi Mitsui Tower, Nihonbashi Muromachi 2-1-1, Chūō, Tokyo On the registration Headquarter: Tokyo Kita (Tokyo) |
| Key people | Osamu Nagayama - Chairman and Tatsuro Kosaka - CEO |
| Revenue | 72.9 billion capital of 47 million yen. Standalone sales of 329.2 billion yen and 344.8 billion yen consolidated (December 2007) |
| Parent | Hoffmann-La Roche (61.62%) |
| Website | www.chugai-pharm.co.jp (in Japanese) |
Chugai's mission is to create innovative drugs for the benefit of patients. As a research-based pharmaceutical company, Chugai specializes in the research, development, production and marketing of prescription pharmaceuticals. We have established the following business processes to create innovative medicines.
For detailed contact information visit location pages below.
Chugai Pharmaceutical Co., Ltd.'s locations around the world
Asia
Clinical Trials sponsored by Chugai Pharmaceutical Co., Ltd.
-
Chugai PharmaceuticalReclutamientoEnfermedad celíacaEstados Unidos, Australia
-
Chugai PharmaceuticalTerminadoDermatitis atópicaEstados Unidos
-
Chugai PharmaceuticalTerminadoVoluntarios SaludablesReino Unido
-
Chugai PharmaceuticalTerminado
-
Chugai PharmaceuticalTerminado
-
Chugai PharmaceuticalTerminadoEnfermedad de alzheimerJapón
-
Chugai PharmaceuticalTerminado
-
Chugai PharmaceuticalTerminado
-
Chugai PharmaceuticalTerminado
-
Chugai PharmaceuticalTerminado